Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual

被引：22

作者：

Pilcher, CD ^{[1
]}

Eron, JJ

Ngo, L

Dusek, A

Sista, P

Gleavy, J

Brooks, D

Venetta, T

DiMassimo, E

Hopkins, S

机构：

[1] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27514 USA

[2] Trimeris Inc, Durham, NC USA

来源：

AIDS | 1999年 / 13卷 / 15期

关键词：

D O I：

10.1097/00002030-199910220-00024

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：2171 / 2173

页数：3

相关论文

共 5 条

[1] Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
Kilby, JM
Hopkins, S
Venetta, TM
DiMassimo, B
Cloud, GA
Lee, JY
Alldredge, L
Hunter, E
Lambert, D
Bolognesi, D
Mathews, T
Johnson, MR
Nowak, MA
Shaw, GM
Saag, MS
[J]. NATURE MEDICINE, 1998, 4 (11) : 1302 - 1307
[2] LALEZARI J, 1999, 6 C RETR OPP INF CHI
[3] Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptide
Rimsky, LT
Shugars, DC
Matthews, TJ
[J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 986 - 993
[4] WEI X, 1999, 6 C RETR OPP INF CHI
[5] A SYNTHETIC PEPTIDE FROM HIV-1 GP41 IS A POTENT INHIBITOR OF VIRUS-MEDIATED CELL-CELL FUSION
WILD, C
GREENWELL, T
MATTHEWS, T
[J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) : 1051 - 1053